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Violence against Women Raises Risk of Cervical Cancer
Ann L. Coker, Ph.D.,1 Claudia Hopenhayn, Ph.D.,2 Christopher P. DeSimone, M.D.,1
Heather M. Bush, Ph.D.,2 and Leslie Crofford, M.D.3

Abstract

Background: An emerging literature suggests that violence against women (VAW), particularly sexual violence,
may increase the risk of acquiring a sexually transmitted infection (STI) and, therefore, may be associated with
cervical cancer development. The purpose of this cross-sectional analysis was to determine if women who had
experienced violence had higher prevalence rates of invasive cervical cancer.
Methods: Women aged 18–88 who joined the Kentucky Women’s Health Registry (2006–2007) and completed a
questionnaire were included in the sample. Multivariate logistic regression analyses were used to adjust odds
ratio (OR) for confounders (e.g., age, education, current marital status, lifetime illegal drug use, and pack-years
of cigarette smoking).
Results: Of 4732 participants with no missing data on violence, cervical cancer, or demographic factors, 103
(2.1%) reported ever having cervical cancer. Adjusting for demographic factors, smoking, and illegal drug use,
experiencing VAW was associated with an increased prevalence of invasive cervical cancer (adjusted OR
[aOR] ¼ 2.6, 95% CI ¼ 1.7-3.9). This association remained significant when looking at three specific types of
VAW: intimate partner violence (IPV) (aOR ¼ 2.7, 95% CI ¼ 1.8-4.0), adult exposure to forced sex (aOR ¼ 2.6, 95%
CI ¼ 1.6-4.3), and child exposure to sexual abuse (aOR ¼ 2.4, 95% CI ¼ 1.4-4.0).
Conclusions: Rates of cervical cancer were highest for those experiencing all three types of VAW relative to those
never experiencing VAW. Because VAW is common and has gynecological health effects, asking about VAW in
healthcare settings and using this information to provide tailored healthcare may improve women’s health
outcomes.

Introduction

V

iolence against women (VAW) is defined by the
United Nations (UN) as ‘‘any act of gender-based violence that results in, or is likely to result in, physical, sexual, or
psychological harm or suffering to women, including threats
of such acts, coercion or arbitrary deprivation of liberty,
whether occurring in public or private life.’’1 Male VAW has
been associated with both psychological and physical morbidity for girls and women.2–4 Specifically, girls exposed to
sexual abuse are at increased risk of substance use,5,6 adolescent pregnancy,7 and subsequent sexual risk-taking behaviors.8 Sexually abused girls are also at increased risk of
forced sex during young adulthood.9
Women who are forced into sexual activities in childhood
or adulthood are also at increased risk of developing sexually
transmitted infections (STI),10 including human papilloma-

virus (HPV) infection.11 Persistent high-risk HPVs are the
necessary etiological agent for cervical neoplasia development12 and occur in almost 100% of cervical cancer cases.13
Sexual abuse, including coercive sexual experiences, has been
linked to both high-risk HPV and cervical squamous intraepithelial lesions in college women14 and among women
prisoners.15 Risk of an STI has consistently been associated
with intimate partner violence (IPV) and particularly with
sexual violence.3,16–21 Finally, IPV has been correlated with an
increased risk of preinvasive cervical neoplasia in three22–24 of
five studies.22–26 Only one study has explored and found an
association between IPV and invasive cervical cancer.24 This
study lacked sufficient power (n ¼ 1152) to provide an accurate estimate of the odds of cervical cancer given exposure to
violence.
The present cross-sectional analysis of the Kentucky Women’s Health Registry (KWHR) will add to the existing
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literature by addressing the association between VAW and
cervical cancer in a much larger sample. This analysis will also
add to the literature by comprehensively defining violence
against women as our primary exposure. IPV frequently cooccurs with child and adult sexual abuse; thus, we defined
VAW to include the lifetime experiences of IPV, forced sex,
and child sexual abuse. We hypothesized that women who
were exposed to VAW would have higher rates of cervical
cancer than would women who were never exposed. Further,
because cigarette smoking interacts with HPV to increase the
risk of cervical neoplasia27 and women experiencing VAW are
significantly more likely to smoke,28 we hypothesized that
smokers exposed to VAW will have the highest cervical cancer rates.
Materials and Methods
Data source
We conducted a cross-sectional analysis of data available
from the KWHR. The registry, begun in 2006, is a comprehensive survey open to all women, aged 18 years, living in
Kentucky. The purpose of the registry is to better care for
Kentucky women by understanding how risk and protective
behavioral factors may differentially affect women’s health
and to give interested women the chance to participate in
medical research. The goal of the survey is to enroll over
25,000 Kentucky women over the next 10 years. Women were
invited to participate in the KWHR through a range of advertisement venues. KWHR brochures are available at the
University of Kentucky in Lexington in all clinics providing
care to women. Registry staff work across the state to recruit
women through state and county health departments, county
agricultural extension offices, private physicians’ offices,
women’s professional organizations, and homemaker organizations. Women can complete the survey online (www.mc
.uky.edu=Kyhealthregistry) or by completing a pen and paper
version of the same survey and mailing the form to the KWHR.
Because this is a large convenience sample of volunteers,
we do not have a refusal rate for participation. The KWHR
survey data are designed as a cohort study. Women are asked
to complete the survey annually. To date (May 2009), 4916
women aged 18 have completed at least one initial survey to
enroll in the KWHR, and the number of women returning to
complete the survey a second or third time is approximately
63%. The majority of women complete this survey online
using a secured website; however, 12.7% completed and
mailed a paper version of the survey. The KWHR was approved by the University of Kentucky Institutional Review
Board. Consent and the Health Insurance Portability and
Accountability Act (HIPAA) were obtained for all participants.
In this analysis, we focused on women who completed the
baseline (first) survey. Of the 4916 women, 59 were excluded
because of missing data on IPV, child abuse, or other forced
sex, and 128 were excluded because of additionally missing
data on smoking status, other substance use, or demographic
data. The final number for these analyses is 4732.
Cervical cancer
Women were asked to provide details about all previous
cancer diagnoses, including cervical cancer. No age at diagnosis data are available. All data are self-reported, and given
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consent issues, the data cannot be verified by medical records.
A dichotomous variable was created to indicate a history of
ever having had cervical cancer (hereafter, cervical cancer
prevalence).
Violence against women
Five items were used to measure lifetime exposure to VAW.
We operationally defined VAW as IPV or forced sexual experiences as an adult or during childhood. Three items were
used to measure IPV: for physical IPV: Has an intimate
partner hit, kicked, punched, or otherwise hurt you?; for
sexual IPV: Has an intimate partner used force (like hitting,
holding down, or using a weapon) to make you have sex?; for
stalking: Has an intimate partner ever repeatedly followed
you, spied on you, made unsolicited phone calls to your place
of work or at home, damaged your property, or stalked you in
any way? Although answers to these questions included experiences in the past year as well as lifetime experiences, we
grouped the positive responses to indicate lifetime IPV because we do not know the age at cervical cancer development,
nor do we know the age at first IPV. We created one dichotomous variable for each of the three IPV types, as well as an
indicator variable for having experienced any of the three
types of IPV. One item measured childhood sexual abuse:
When you were a child, did any parent, stepparent, guardian
or any other person make you have sex (any sex act, not just
intercourse) by using force or by threatening to harm you or
someone close to you? One item was included to assess if the
woman had ever experienced forced sex by someone other
than an intimate partner: Has anyone other than an intimate
partner or anyone else used force (like hitting, holding down,
or using a weapon) to make you have sex? Again, responses
were dichotomized.
Women may have experienced multiple forms of VAW
during their lifetime; the combined effects of violence as a
child and adult may increase the risk of STIs and cervical
cancer. Therefore, we created the following categories of
VAW: experiencing all three forms, experiencing any two of
the three forms, and experiencing any one of the three forms.
The referent group for these categories was those women who
never experienced VAW.
Potential confounders=effect modifiers
The KWHR includes the following sets of variables used
here as either potential confounders or effect modifiers. Demographic factors included were age (continuous variable),
current marital status, race=ethnicity (white non-Hispanic vs.
other), education (ordinal variable ranging from no high
school diploma through postgraduate education), and private
health insurance coverage (current private health insurance
vs. no private health insurance). Smoking was characterized
as lifetime smoking status (dichotomous variable), duration of
smoking (age at first and last smoking), and pack-years of
smoking. Pack-years are based on years of smoking and the
average number of packs of cigarette usually smoked per day.
Illegal drug use was defined as ever having used cocaine,
heroin, methamphetamines, or ecstasy (dichotomous variable). The survey included a question characterizing lifetime
Pap smear screening frequency, but we chose not to include
this variable because we do not know the screening patterns
prior to cervical cancer development. Further Pap screening
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recommendations change after cervical cancer diagnosis and
treatment.
Smoking, along with high-risk HPV, is an etiological factor
in cervical cancer development. Therefore, effect modification
by smoking was evaluated for the relationship between VAW
exposure and cervical cancer prevalence. The following
combined exposure groupings were used: (1) VAW (þ) and
smoking (þ), (2) VAW (þ) and smoking (), (3) VAW () and
smoking (þ), compared with VAW () and smoking () as
the referent group.

Compared with women never experiencing VAW, those
who had ever experienced VAW were significantly younger,
had less education, and were less likely to currently have
private health insurance and to be married ( p < 0.01) (Table 1).
Additionally, women experiencing VAW were significantly
more likely to have ever had an STI, to have ever used illegal
drugs, to smoke cigarettes, and to smoke more cigarettes over
a longer period than those never experiencing VAW. The
following factors were included as confounders in subsequent
multivariate models: age, education, current marital status,
lifetime illegal drug use, and pack-years of cigarette smoking.
Our two indicators of socioeconomic status (SES), current
health insurance and education, were correlated (coefficient ¼ 0.292, p < 0.0001). We opted to include education level
in multivariate models because educational attainment reflects lifetime status vs. current SES. We did not have a measure of SES at the time of cervical cancer development. History
of having an STI was not included as a confounder because it
may be in the causal pathway from VAW (particularly sexual)
and cervical cancer.
Table 2 presents the multivariate logistic regression analysis estimating odds ratios (ORs) for cervical cancer and all
forms of VAW combined and by three types of VAW: IPV,
forced sex by nonpartner, and child sexual abuse. Two percent (n ¼ 103) of the 4732 women included in this analysis
reported ever having cervical cancer. Among the 1945 women
who had ever experienced VAW, 3.5% had ever had cervical
cancer, compared with 1.3% of women never experiencing
VAW (aOR ¼ 2.6, 95% CI 1.7-3.9). Cervical cancer rates were
also higher for women experiencing IPV (aOR ¼ 2.7, 95% CI
1.8-4.0), forced sex by a nonpartner (aOR ¼ 2.6, 95% CI 1.64.0), and child sexual abuse (aOR ¼ 2.4, 95% CI 1.4-4.0).
When summing the total number of the three possible
VAW types queried (e.g., IPV, child sexual abuse, and forced
sex by a nonpartner), there was a trend of increasing cervical

Statistical analysis
Chi-square tests were performed for dichotomous analyses, and t tests were used for continuous and ordinal outcomes (e.g., age, years smoked, and pack-years of smoking).
Decisions about the inclusion of confounders were based on
the variable being association with VAW, being known risk
factors for cervical cancer, and not being in the causal pathway between VAW and cervical cancer. Given the large
sample size, only associations with VAW of p < 0.01 were
noted. Given the small number of cervical cancer cases, we
explored additive interactions and used multivariate models to adjust for other confounders.
Results
Lifetime prevalence of VAW among those completing the
KWHR was relatively high (41.1%). In this sample, 35.9%
experienced IPV, 9.7% of women reported forced sex by
someone other than an intimate partner during their adult life,
and 8.4% experienced sexual abuse during their childhood.
Further, among the 1700 women who had ever experienced
IPV, 20.2% reported forced sex and 13.8% reported child
sexual abuse.

Table 1. Demographic and Risk Factors and Lifetime Violence Against Women (VAW), n ¼ 4732
% with risk factor by
lifetime VAW status

Demographic factors
Mean age (standard error)
Highest education
Less than high school
High school graduate=GED
Some college
Associate degree
College graduate
Postgraduate
Currently have private health insurance
Currently married
Non-Hispanic white race
Other cervical cancer risk factors
Women ever told of a sexually transmitted infection
Ever used illegal druga
Ever smoker
Mean years smokingb (standard error)
Mean pack-yearsb (standard error)

VAW

No VAW

n ¼ 1945
44.89 (0.28)

n ¼ 2787
47.37 (0.29)

Difference in risk
factor by VAW status
Test (p value)
t ¼ 5.92 (<0.0001)

1.9%
11.1%
23.8%
12.0%
20.3%
31.0%
82.7%
54.3%
90.5%

0.8%
10.0%
17.1%
9.2%
23.5%
39.4%
91.7%
67.1%
92.5%

t ¼ 7.48 (<0.0001)
chi-square ¼ 86.57 (<0.0001)
chi-square ¼ 79.41 (<0.0001)
chi-square ¼ 6.01 (0.01)

24.1%
19.0%
50.4%
8.84 (0.29)
7.51 (0.29)

12.0%
6.5%
29.9%
5.35 (0.19)
4.21 (0.21)

chi-square ¼ 118.68 (<0.0001)
chi-square ¼ 175.78 (<0.0001)
chi-square ¼ 202.83 (<0.0001)
t ¼ 11.15 (<0.0001)
t ¼ 9.34 (<0.0001)

a

Illegal drugs use includes cocaine, heroin, methamphetamines, or ecstasy.
Nonsmokers received value of 0.

b
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Table 2. Violence against Women and Prevalence of Invasive Cervical Cancer, n ¼ 4732
Ever had cervical cancer (n ¼ 103)
N in strata

n (%)

Adjusted odds ratioa (95% CI)

1945
2787

68 (3.5%)
35 (1.3%)

2.6 (1.7-3.9)
1.0 (referent)

1700
467
1158
1054
3032
460
4272
397
4335

64
26
49
45
39
25
77
20
83

2.7
2.7
2.5
2.6
1.0
2.6
1.0
2.4
1.0

Violence against womanb
Ever
Never
By type of VAW
Any IPV
Sexual IPV
Physical IPV
Stalking by an intimate
No IPV
Adult exposure to forced sex by nonpartner
No forced sex
Child exposure to sexual abuse
No child sexual abuse
Number of types of VAW experienced over life span
Experienced all three types of VAW
Experienced two typesc
Experienced one typed
Never experienced VAW

122
368
1455
2787

(3.8%)
(5.6%)
(4.2%)
(4.3%)
(1.3%)
(5.4%)
(1.8%)
(5.0%)
(1.9%)

10 (8.2%)
21 (5.7%)
37 (2.5%)
35 (1.3%)
p for trend

(1.8-4.0)
(1.6-4.4)
(1.6-3.7)
(1.7-4.0)
(referent)
(1.6-4.3)
(referent)
(1.4-4.0)
(referent)

6.4 (2.7-14.9)
4.0 (2.2-7.3)
1.9 (1.2-3.1)
1.0 (referent)
chi-square ¼ 7.39 (0.007)

a

Odds ratio (aOR) adjusted for age, education, current marital status, pack-years smoking, ever used an illegal drug.
Defined to include ever experiencing stalking, physical or sexual abuse within a partnership, adult exposure to forced sex by someone
other than a partner, or child exposure to sexual abuse.
c
60.1% IPV and forced sex by a nonpartner, 30.7% IPV and child sexual abuse, 9.2% forced sex by a nonpartner and child sexual abuse.
d
85.5% IPV, 8.8% child sexual abuse, and 5.7% forced sex by a nonpartner.
b

cancer prevalence with increasing types of VAW experienced
(chi-square ¼ 7.66, p for trend ¼ 0.007). Women who experienced all three types of VAW had the highest cervical cancer
rates (aOR ¼ 6.4, 95% CI 2.7-14.9) (Table 2).
Lifetime smoking status and VAW appear to interact to
increase cervical cancer rates. Among the 980 women who
had ever smoked and experienced VAW, 45 women (4.6%)
had ever had cervical cancer compared with 17 women (0.9%)
who never smoked or experienced VAW (aOR ¼ 4.9, 95% CI
2.6-8.9). Among the 965 women who were never smokers but
did experience VAW, 23 (20.4%) had cervical cancer
(aOR ¼ 2.7, 95% CI 1.4-5.1). Similarly, among the 834 women
never experiencing VAW who were smokers, 18 (2.2%) had
ever had cervical cancer (aOR ¼ 2.3, 95% CI 1.1-4.7).
Discussion
To our knowledge, this is the first study to report an association between cervical cancer and three forms of VAW:
IPV, exposure to child sexual abuse, and adult forced sex.
Experiencing multiple types of VAW increased the prevalence
of cervical cancer. Cigarette smoking, an acknowledged cause
of cervical cancer, appears to further increase cervical cancer
rates in combination with VAW. Because cervical cancer is a
rare event, we needed the large sample from the KWHR
(n ¼ 4732), which has sufficient study power (95%) to detect a
rate ratio of 2.0 with a cervical cancer prevalence in the population of 2.0%. We were able to measure both physical and
sexual abuse and adjust for confounding factors (e.g., age,
education, marital status, smoking, and illegal drug use).
Our finding that all three forms of VAW were associated
with cervical cancer is consistent with the growing literature

showing that sexual assaults and abuse are associated with an
increased risk of an STI, including infection with human immunodeficiency virus (HIV)29 and HPV,30 and with an increased risk of cervical dysplasia.15,22,24
Mechanistically, how might VAW increase the risk of cervical cancer? Figure 1 provides a conceptual model for pathways by which VAW may be associated with cervical cancer.
For this analysis, we only had data on VAW, smoking, and
cervical cancer; however, it is also plausible that VAW may
impact cervical cancer risk through important constructs depicted in Figure 1. For example, VAW, particularly sexual
violence, influences a woman’s control over her choice to
engage in sexual intercourse and use of contraception. Abusive partners may not be monogamous and may also refuse
barrier methods of contraception, thus limiting women’s
ability to protect themselves from STIs,18 including HPV.
VAW may thus directly influence the risk of cervical cancer
through increasing risk of acquiring and maintaining a persistent HPV infection, the necessary event for cervical cancer
development.12 A consistent literature documents that women experiencing VAW are at increased risk of acquiring an
STI.3,19,20,31–42 VAW may influence cervical cancer risk indirectly through stress and associated immune suppression.
Women experiencing VAW are well documented to have
higher self-perceived stress levels and higher rates of depression and anxiety disorders.3 Increased stress may affect
cervical neoplasia risk through changes to a woman’s immune surveillance.43–47 Immune compromised subjects are
more likely to develop a range of infections, including cervical
dysplasia and genital condyloma.48 Women infected with
HIV are known to be at increased risk of invasive cervical
cancer.47 Two recent studies indicate that higher stress levels
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• Child Sexual Abuse
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+ Cervical Cancer
FIG. 1.

Conceptual model for VAW and cervical cancer.

increased the odds of cervical neoplasia progression49 or being diagnosed with a higher grade lesion.22 VAW may influence cervical cancer risk through smoking; women who
have experienced VAW are significantly more likely to
smoke.28 In addition to HPV infection, cigarette smoking has
been identified as an important cofactor for development of
cervical cancer.13,50 Smoking may affect cervical cancer risk by
influencing early immune responses to HPV and result in
persistent HPV infection.51 Smoking and high-risk HPVs biologically interact to cause cervical cancer.27 Our finding that
women who smoke and were exposed to VAW had the
highest cervical cancer rates is consistent with this observation, yet we lack biological measurement of HPV.
Finding that VAW is associated with cervical cancer in this
cross-sectional sample suggests that confirmatory results
should be sought using a study design better able to address
the risk of preinvasive cervical lesions. Future studies are also
needed to investigate potential biological mechanisms by
which violence heightens the risk for cervical cancer. Additional studies are needed to address the life course of VAW
and its potential impact on cervical cancer risk. Such an understanding may inform intervention development to reduce
the impact of abuse on cervical cancer risk.
There are limitations to this cross-sectional analysis that
deserve mention. It is impossible to infer causality from observational data. As with most cross-sectional analyses, we do
not know the timing of VAW relative to cervical cancer development because we do not have dates of violence or cancer
occurrence. We can be reasonably certain that child sexual
abuse occurred prior to cervical cancer. The greater uncertainty lies with the temporal sequence for IPV and cancer. The
average age at first IPV is 25.7 years,52 and the mean age at
cervical cancer diagnosis was 49.8. (www.bcr.uby.edu). With
this information, it is reasonable to conclude that IPV and,
likely, forced sex preceded cervical cancer diagnosis for the

majority of the cervical cancer cases included in this analysis.
Because three VAW items were included in the survey, we
cannot define VAW by frequency or duration of the experience. Thus, we cannot, for example, determine whether repeated sexual IPV causes greater odds of cervical cancer.
Although multivariate analyses were conducted to adjust for
confounders, residual confounding remains a potential bias.
Additionally, we have no information on the HPV status or
sexual activity of women’s male partners. As all measures
were based on women’s self-report, the cervical cancer diagnosis was not confirmed by any laboratory tests or medical
record data.
Selection bias may result from the voluntary nature of the
KWHR sample, such that women experiencing VAW may
be less likely to participate. The rates of VAW would then be
lower in this sample. To explore this possibility, we compared
the lifetime rates of physical or sexual IPV based on the
KWHR (24.4%) with the rate from a report by the Centers for
Disease Control and Prevention’s Behavioral Risk Factors
Surveillance System (BRFSS) of 23.6% lifetime physical or
sexual violence by a current or former intimate partner.53 The
BRFSS uses a similar approach to defining lifetime IPV, yet
subjects are sampled using random digit dial telephone survey methodology. Additionally, the VAW items were included at the end of the survey, and much like the BRFSS
survey, VAW was not the focus of the KWHR survey. Finding
similar rates provides some evidence that selection bias may
not be operational.
The women included in the KWHR are of higher SES than
Kentucky women in general. To better describe how this
KWHR sample differs from other population-based samples
of Kentucky women, we compared the demographic profile
of women completing the KWHR survey with Kentucky
women who recently completed the Kentucky BRFSS telephone survey.53 BRFSS uses a random digit dialing approach
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to sample household to participate in an annual phone-based
survey of health behaviors. Based on 2005 BRFSS data for
Kentucky women, 17.2% had no health insurance compared
with 12.7% of women in the KWHR. Women in the KWHR
were less likely to have ever smoked (38%) than were women
completing the BRFSS (49%). However, women in the KWHR
were more likely to currently be overweight (59%) than were
women completing the BRFSS (55%). Because smoking is
more prevalent in lower socioeconomic populations, our
finding of an association between IPV and cervical cancer in a
higher socioeconomic population suggests these findings may
be generalized to all women in Kentucky or the United States.
How do the prevalence rates of cervical cancer compare
with population-based rates of cervical cancer prevalence in
Kentucky? Although Kentucky does have a Surveillance and
Epidemiology End Results Registry begun in 1995, this registry has not been collecting both incidence and survival data
for sufficient time to accurately calculate prevalence; therefore, we cannot compare our 2% prevalence in women participating in the KWHR with a population-based estimate for
Kentucky women.
From a clinical perspective, VAW is common and does
influence gynecological health. Physicians and other healthcare providers caring for women should consider asking
women about violence and develop protocols to address the
short-term and longer-term consequences of this violence.
Efforts to address substance use, including smoking, and
other risk-taking behaviors may be important interventions to
reduce the risk of subsequent violence revictimization.
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